Compare Piramal Healthcare with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs ELDER PHARMA - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES ELDER PHARMA PIRAMAL ENTERPRISES/
ELDER PHARMA
 
P/E (TTM) x -30.9 -0.2 - View Chart
P/BV x 1.1 0.1 1,051.2% View Chart
Dividend Yield % 2.2 0.0 -  

Financials

 PIRAMAL ENTERPRISES   ELDER PHARMA
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
ELDER PHARMA
Jun-14
PIRAMAL ENTERPRISES/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs3,303380 869.1%   
Low Rs1,797188 955.7%   
Sales per share (Unadj.) Rs716.5491.2 145.9%  
Earnings per share (Unadj.) Rs79.7-3.2 -2,505.1%  
Cash flow per share (Unadj.) Rs107.914.4 748.9%  
Dividends per share (Unadj.) Rs28.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs1,477.5376.5 392.4%  
Shares outstanding (eoy) m184.4520.54 898.0%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.60.6 615.5%   
Avg P/E ratio x32.0-89.3 -35.8%  
P/CF ratio (eoy) x23.619.7 119.9%  
Price / Book Value ratio x1.70.8 228.8%  
Dividend payout %35.10-   
Avg Mkt Cap Rs m470,2925,833 8,062.1%   
No. of employees `0007.8NA-   
Total wages/salary Rs m22,5042,179 1,032.7%   
Avg. sales/employee Rs Th16,899.4NM-  
Avg. wages/employee Rs Th2,877.7NM-  
Avg. net profit/employee Rs Th1,879.9NM-  
INCOME DATA
Net Sales Rs m132,15310,089 1,309.9%  
Other income Rs m3,128257 1,219.0%   
Total revenues Rs m135,28110,346 1,307.6%   
Gross profit Rs m66,290-792 -8,371.0%  
Depreciation Rs m5,202361 1,439.7%   
Interest Rs m44,0972,756 1,599.9%   
Profit before tax Rs m20,119-3,653 -550.8%   
Minority Interest Rs m3,1940-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m8,611125 6,880.8%   
Profit after tax Rs m14,701-65 -22,496.1%  
Gross profit margin %50.2-7.8 -639.1%  
Effective tax rate %42.8-3.4 -1,249.3%   
Net profit margin %11.1-0.6 -1,717.4%  
BALANCE SHEET DATA
Current assets Rs m122,7429,240 1,328.4%   
Current liabilities Rs m310,8109,998 3,108.8%   
Net working cap to sales %-142.3-7.5 1,894.9%  
Current ratio x0.40.9 42.7%  
Inventory Days Days2346 49.8%  
Debtors Days Days3960 64.8%  
Net fixed assets Rs m116,90410,124 1,154.8%   
Share capital Rs m369206 179.3%   
"Free" reserves Rs m272,1615,582 4,875.4%   
Net worth Rs m272,5307,734 3,524.0%   
Long term debt Rs m270,1964,889 5,526.6%   
Total assets Rs m856,26122,882 3,742.1%  
Interest coverage x1.5-0.3 -447.7%   
Debt to equity ratio x1.00.6 156.8%  
Sales to assets ratio x0.20.4 35.0%   
Return on assets %6.911.8 58.4%  
Return on equity %5.4-0.8 -638.4%  
Return on capital %12.422.3 55.7%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m15,200307 4,957.7%   
Fx outflow Rs m4,889125 3,901.7%   
Net fx Rs m10,312181 5,687.6%   
CASH FLOW
From Operations Rs m-115,97511,754 -986.7%  
From Investments Rs m-8,265-561 1,474.6%  
From Financial Activity Rs m107,525-6,762 -1,590.2%  
Net Cashflow Rs m-16,6504,432 -375.7%  

Share Holding

Indian Promoters % 52.9 39.6 133.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 7.5 53.3%  
FIIs % 26.6 16.8 158.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 36.1 45.7%  
Shareholders   93,274 16,479 566.0%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   AJANTA PHARMA  FDC.  SUN PHARMA  FRESENIUS KABI ONCO.  TTK HEALTHCARE  

Compare PIRAMAL ENTERPRISES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex Crashed 600 Points Today(Closing)

Indian share markets witnessed a sharp sell-off today and ended their session deep in the red.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY21); Net Profit Up 22.1% (Quarterly Result Update)

Aug 25, 2020 | Updated on Aug 25, 2020

For the quarter ended June 2020, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 22.1% YoY). Sales on the other hand came in at Rs 29 bn (down 16.2% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY20); Net Profit Up 11.7% (Quarterly Result Update)

Feb 5, 2020 | Updated on Feb 5, 2020

For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 16.5% YoY). Sales on the other hand came in at Rs 36 bn (up 14.6% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

More Views on News

Most Popular

My View on ITC(Fast Profits Daily)

Oct 23, 2020

What do the charts say about ITC?

Why ITC and not HUL is my Idea of a Good Investment Right Now(Views On News)

Oct 15, 2020

Rahul Shah discusses HUL's lost decade and its implications for ITC.

PSU Banks Will Move Up Again(Profit Hunter)

Oct 27, 2020

My charts tell me PSU banks are set for a rebound.

Why India's Drone Revolution is a 4x Profit Opportunity(Profit Hunter)

Oct 16, 2020

My research on India's leading defence companies brought me to one major player in drone manufacturing.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Oct 28, 2020 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - PFIZER COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS